The polarized γδT17 cells or γδTregs produce abundant IL-17 or TGF-β, triggering a cascade of suppressive immune responses to promote CRC progression (Figure 2) (32, 73, 74). The gene discussed is IL17A; the disease is colorectal carcinoma.